Pharmazz’s Lyfaquin, approved by DGCI, proves wonder in managing massive blood loss and hypovolemic shock

The discovery of Lyfaquin as a resuscitative agent was made at Midwestern University in the USA and developed by Pharmazz to bring this product to the patient for the first time. The pharma major Pharmazz India has...

Bihari researcher with other two summarize interactions at interface of SARS coronavirus ‘S’ protein and human ACE2 receptor protein

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a newly emerging, highly transmissible, and pathogenic coronavirus in humans that has caused global public health emergencies and economic crises. Since the...

Senior paediatrician and key member in developing two Indian public health vaccine joins Patna AIIMS: A doctor from Bihar to Bihar

Among the best minds of India behind this success includes a doctor from Bihar Dr. Chandra Mohan. Under 5 mortality rates in India has seen a significant improvement from 126 per 1000 live births in 1990, 83.1 in 2000 to now...